AQR Capital Management 13F: Adds $140M to Albemarle (ALB) Stake
AQR Capital Management significantly increased its holdings in specialty chemicals producer Albemarle Corporation during the period.
Reviewed by automated data checks against the source filing. How we make and check alerts
AQR Capital Management added 822,755 shares to its stake in Albemarle Corporation ($ALB), a 213.94% increase, according to a 13F filing with the SEC dated May 15, 2026. It reported 1,207,328 shares worth $205.75 million at the end of the quarter.
Since the filing, $ALB is down 4.9% after 1 week, down 6.1% after 1 month and down 46.8% to date (from the $179.32 close on May 15, 2026).
Find the original: AQR Capital Management 13F filings on SEC EDGAR
Key Points
- AQR Capital Management grew its Albemarle Corporation stake by 213.9%, adding 822,755 shares to finish the period with 1,207,328 shares worth roughly $205.8 million.
- Albemarle shares trade near $170.42, with a forward P/E of about 10.0 and a 52-week trading range spanning from $79.30 to $221.00.
- Wall Street firms tracking the specialty chemicals provider include RBC Capital, Mizuho, and Barclays, which maintain mixed ratings on the stock.
Get $ALB trade alerts by text
We text you when insiders, Congress or big funds trade $ALB. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Albemarle Corporation alert may contain errors. Disclosures
AQR Capital Management Expands Position in Albemarle Corporation
AQR Capital Management grew its investment in Albemarle Corporation (NYSE: ALB) during the period, according to a Form 13F filing submitted to the SEC. The filing reflects holdings as of the reporting period and may not represent the investor's current position.
Details on the Share Increase
The fund added 822,755 shares to its portfolio, driving a 213.9% increase from its prior count of 384,573 shares. That brought AQR Capital Management's total holding to 1,207,328 shares. The reported value of the position reached approximately $205.8 million based on the filing data.
Albemarle Stock Price and Valuation Context
Albemarle shares traded around $170.42 on Sunday. The specialty chemicals producer carries a market value of about $13.3 billion. The stock features a forward P/E of 10.0 and a 52-week trading range spanning from $79.30 to $221.00.
Recent Analyst Updates and Price Targets
Wall Street firms have actively adjusted their outlooks on the specialty chemicals producer. On October 15, 2026, RBC Capital maintained an Outperform rating while lowering its price target from $157.00 to $129.00. Mizuho upgraded the stock on October 14, 2026, keeping an Outperform rating with a $130.00 target. Barclays initiated coverage on October 13, 2026, with an Equal-Weight rating and a $109.00 price target. Argus Research maintained a Buy rating on October 7, 2026, reducing its target from $230.00 to $135.00. UBS kept a Buy rating on October 5, 2026, lowering its target from $175.00 to $150.00. Mizuho maintained a Neutral rating on October 1, 2026, with a $130.00 target. JP Morgan kept a Neutral rating on August 25, 2026, with a $140.00 target, and RBC Capital previously maintained an Outperform rating on August 10, 2026, with a $166.00 target. The stock currently holds a consensus Buy recommendation from 20 analysts with a target mean price of $171.56.
Specialty Chemicals Operations in North Carolina
Headquartered in Charlotte, North Carolina, Albemarle Corporation provides energy storage solutions, specialty chemicals, and clean fuels technologies worldwide. The company operates segments focused on lithium compounds for electric vehicles and electronics, bromine and specialized chemicals, and petroleum catalysts.
What to Watch Next for Albemarle
Investors tracking Albemarle will look toward the company's next earnings report scheduled for November 4, 2026, for further insight into its financial performance. Institutional filings provide a backward-looking snapshot, and subsequent disclosures will show whether large funds maintain these positions.
Source: AQR Capital Management's 13F filing on $ALB (May 15, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: AQR Capital Management 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
